Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (P01 CA163205, R01 CA222804-03, T32 CA082084-19)

This publication has 38 references indexed in Scilit: